These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beings. Krohn K; Ranki A; Lusso P; Moss B; Ashorn P; Arthur LO; Putney SD; Gallo RC J Med Primatol; 1989; 18(3-4):363-9. PubMed ID: 2547967 [TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120. Berman PW; Groopman JE; Gregory T; Clapham PR; Weiss RA; Ferriani R; Riddle L; Shimasaki C; Lucas C; Lasky LA Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5200-4. PubMed ID: 2455898 [TBL] [Abstract][Full Text] [Related]
9. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. Wahren B; Morfeldt-Månsson L; Biberfeld G; Moberg L; Sönnerborg A; Ljungman P; Werner A; Kurth R; Gallo R; Bolognesi D J Virol; 1987 Jun; 61(6):2017-23. PubMed ID: 3033328 [TBL] [Abstract][Full Text] [Related]
10. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein. Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708 [TBL] [Abstract][Full Text] [Related]
11. Absence of cytotoxic antibody to human immunodeficiency virus-infected cells in humans and its induction in animals after infection or immunization with purified envelope glycoprotein gp120. Nara PL; Robey WG; Gonda MA; Carter SG; Fischinger PJ Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3797-801. PubMed ID: 3473484 [TBL] [Abstract][Full Text] [Related]
12. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men. Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037 [TBL] [Abstract][Full Text] [Related]
13. A synthetic peptide from the first conserved region in the envelope protein gp160 is a strong T-cell epitope in HIV-infected chimpanzees and humans. Nehete PN; Schapiro SJ; Johnson PC; Murthy KK; Satterfield WC; Sastry KJ Viral Immunol; 1998; 11(3):147-58. PubMed ID: 9918406 [TBL] [Abstract][Full Text] [Related]
14. Recombinant HIV structural proteins detect specific cellular immunity in vitro in infected individuals. Torseth JW; Berman PW; Merigan TC AIDS Res Hum Retroviruses; 1988 Feb; 4(1):23-30. PubMed ID: 2835070 [TBL] [Abstract][Full Text] [Related]
15. An immunovirological study of central nervous system involvement during HIV-1 infection of chimpanzees. Grimaldi LM; Murthy KK; Martino G; Furlan R; Franciotta D; Eichberg JW J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Sep; 13(1):12-7. PubMed ID: 8797680 [TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immunity to recombinant human immunodeficiency virus (HIV) antigens in HIV-infected populations. Reddy MM; Grieco MH J Infect Dis; 1989 Jan; 159(1):120-2. PubMed ID: 2909630 [No Abstract] [Full Text] [Related]
17. Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1. Girard M; Meignier B; Barré-Sinoussi F; Kieny MP; Matthews T; Muchmore E; Nara PL; Wei Q; Rimsky L; Weinhold K J Virol; 1995 Oct; 69(10):6239-48. PubMed ID: 7666524 [TBL] [Abstract][Full Text] [Related]
18. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children. Borkowsky W; Krasinski K; Moore T; Papaevangelou V AIDS Res Hum Retroviruses; 1990 May; 6(5):673-8. PubMed ID: 2113821 [TBL] [Abstract][Full Text] [Related]
19. Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens. Daftarian MP; Diaz-Mitoma F; Creery WD; Cameron W; Kumar A Clin Diagn Lab Immunol; 1995 Nov; 2(6):712-8. PubMed ID: 8574836 [TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immune proliferative responses to HIV-1 of chimpanzees vaccinated with different vaccinia recombinant viruses. Van Eendenburg JP; Yagello M; Girard M; Kieny MP; Lecocq JP; Muchmore E; Fultz PN; Riviere Y; Montagnier L; Gluckman JC AIDS Res Hum Retroviruses; 1989 Feb; 5(1):41-50. PubMed ID: 2470398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]